Han Qi
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (25 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers)Liver Disease Diagnosis and Treatment (12 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaFrontiers in Immunology
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Han Qi
40 papers receiving 372 citations
Peers
Comparison fields: 5 of 40
- Pulmonary and Respiratory Medicine 201
- Hepatology 158
- Oncology 151
- Surgery 66
- Epidemiology 58
Countries citing papers authored by Han Qi
This map shows the geographic impact of Han Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Qi more than expected).
Fields of papers citing papers by Han Qi
This network shows the impact of papers produced by Han Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Qi. The network helps show where Han Qi may publish in the future.
Co-authorship network of co-authors of Han Qi
This figure shows the co-authorship network connecting the top 25 collaborators of Han Qi. A scholar is included among the top collaborators of Han Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Qi. Han Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 4 | |
| 5 | 5 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 5 | |
| 11 | 2 | |
| 12 | 4 | |
| 13 | 2 | |
| 14 | 3 | |
| 15 | 9 | |
| 16 | 3 | |
| 17 | 8 | |
| 18 | 4 | |
| 19 | 23 | |
| 20 | 4 |
About Han Qi
Han Qi is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Oncology, having authored 45 papers that have together received 375 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers) and Liver Disease Diagnosis and Treatment (12 papers). The work is most often cited by research in Hepatology (158 citations), Pulmonary and Respiratory Medicine (201 citations) and Oncology (151 citations). Han Qi has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Weijun Fan, Weijun Fan, Lujun Shen, Shuanggang Chen, Ze Song, Lin Xie, Fei Cao, Fei Cao, Yaobin Lin and Yizhi Wang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.